Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Depauw, S; Heilmann, RM; Whitehouse-Tedd, K; Hesta, M; Steiner, JM; Suchodolski, JS; Janssens, GPJ (2014)
Publisher: European Association of Zoos and Aquaria
Languages: English
Types: Article

Classified by OpenAIRE into

mesheuropmc: fluids and secretions
Gastrointestinal disease is omnipresent in captive cheetahs (Acinonyx jubatus), in contrast to its freeranging populations. The current study aimed to evaluate the effect of diet type (meat-only whole prey) on gastrointestinal health in captive cheetahs by measuring faecal and serum concentrations of S100/calgranulins. This paper reports faecal S100A12 and calprotectin concentrations in 12 captive cheetahs fed supplemented beef versus whole rabbit for one month in a cross-over design. Also, serum S100A12 and calprotectin concentrations were determined in four cheetahs fed whole rabbit and six cheetahs fed supplemented beef, and these were compared to the faecal concentrations of the respective marker proteins. Both the immunoassay for canine calprotectin and canine S100A12 were precise and reproducible for use with serum samples and faecal extracts. Whereas the assay for S100A12 was linear and accurate, an inconsistent linearity of the canine calprotectin assay was observed and could be indicative of an insufficient cross-reactivity of the specific antibody used for this assay. Serum concentrations of S100A12 and calprotectin were not altered by diet type, and were not correlated with the respective concentrations in faeces. Numerically (P=0.241) greater calprotectin concentrations and greater (P=0.041) faecal S100A12 concentrations were detected in cheetahs fed supplemented beef compared with whole rabbit. These findings demonstrate that whole prey feeding may decrease intestinal inflammation in the captive cheetah. Consequently, the relation between diet type and intestinal inflammatory conditions in the captive cheetah warrants further investigation.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • Costa F., Mumolo M.G., Bellini M., Romano M.R., Ceccarelli L., Arpe P., Sterpi C., Marchi S., Maltinti G. (2003) Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Digestive and Liver Disease 35: 642-647.
    • Depauw S., Hesta M., Whitehouse-Tedd K., Vanhaecke L., Verbrugghe A., Janssens, G.P.J. (2011) Animal fibre: the forgoetn nutrient in strict carnivores? First insights in the cheetah. Journal of Animal Physiology and Animal Nutrition 97: 146-157.
    • Depauw S., Bosch G., Hesta M., Whitehouse-Tedd K., Hendriks W., Kaandorp J., Janssens, G.P.J. (2012) Fermentation of animal components in strict carnivores: a comparative study with cheetah fecal inoculum. Journal of Animal Science 90: 2540-2548.
    • D'Inca R., Dal Pont E., Di Leo V., Ferronato A., Fries W., Veotrato M.G., Martines D., Sturniolo G.C. (2008) Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease. International Journal of Colorectal Disease 22: 429-437.
    • Fagerholl M.K. (2000) Calprotectin, a faecal marker of organic gastrointestinal abnormality. The Lancet 356: 1783-1784.
    • Foell D., Kucharzik T., Kraft M., Vogl T., Sorg C., Domschke W., Roth J. (2003) Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic acute active inflammatory bowel disease. Gut 52: 847-853.
    • Foell D., Witkowski H., Roth J. (2009) Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. Gut 58: 859-868.
    • Grellet A., Heilmann R.M., Feugier A., Lecoindre P., Hernandez J., Freiche V., Peeters D., Suchodolski J.S., Steiner J.M. (2011) Fecal calprotectin concentration in adult dogs with acute and chronic gastrointestinal disease. Journal of Veterinary Internal Medicine 25: 1486-1487 (abstract).
    • Heilmann R.M., Suchodolski J.S., Steiner J.M. (2008) Development and analytic validation of a radioimmunoassay for the quantifcation of canine calprotectin in serum and feces from dogs. American Journal of Veterinary Research 69: 845-853.
    • Heilmann R.M., Suchodolski J.S., Steiner J.M. (2011a) Development and analytic validation of an immunoassay for the quantifcation of canine S100A12 in serum and fecal samples and its biological variability in serum from healthy dogs. Veterinary Immunology and Immunopathology 144: 200-209.
    • Heilmann R.M., Guard B.C., Weber K., Suchodolski J.S., Steiner J.M. (2011b) Development and analytical validation of an enzyme-linked immunosorbent assay for the quantifcation of canine calprotectin in serum and feces from dogs. Journal of Veterinary Internal Medicine 25: 693 (abstract).
    • Heilmann R.M., Grellet A., Allenspach K., Lecoindre P., Day M.J., Procoli F., Grützner N., Suchodolski J.S., Steiner J.M. (2012a) Fecal S100A12 concentrations are increased in dogs with inflammatory bowel disease. Journal of Veterinary Internal Medicine 26: 767 (abstract).
    • Heilmann R.M., Jergens A.E., Ackermann M.R., Barr J.W., Suchodolski J.S., Steiner J.M. (2012b) Serum canine calprotectin concentrations in dogs with idiopathic inflammatory bowel disease. American Journal of Veterinary Research 73: 1900-1907.
    • Johne B., Fagerhol M.K., Lyberg T., Prydz H., Brandtzaeg P., NaessAndresen C.F., Dale I. (1997) Functional and clinical aspects of the myelomonocyte protein calprotectin. Journal of Clinical Pathology: Molecular Pathology 50: 113-123.
    • Kaiser T., Langhorst T., Witkowski H., Becker K., Friedrich A.W., Rueefr A., Dobos G.J., Roth J., Foell D. (2007) Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 56: 1706-1713.
    • Konikof M.R., Denson L.A. (2006) Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflammatory Bowel Disease 12: 524-534.
    • Kotsch V., Kubber-Heiss A., Url A., Walzer C., Schmidt R. (2002) Diseases of captive cheetahs (Acinonyx jubatus ) within the European Endangered Species Program (EEP) - a 22-year retrospective histopathological study. Wiener Tierärztliche Monatsschrift 89: 341-350.
    • Leach S.T., Yang Z., Messina I., Song C., Geczy C.L., Cunningham A.M., Day A.S. (2007) Serum and mucosal S100 proteins, calprotectin (S100A8/ S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 42: 1321-1331.
    • Matsui T., Matsukawa Y., Sakai T., Nakamura K., Aoike A., Kawai K. (1995) Eefct of ammonia on cell-cycle progression of human gastric-cancer cells. European Journal of Gastroenterology and Hepatology 7: S79-S81.
    • Munson L. (1993) Diseases of captive cheetahs (Acinonyx jubatus ) - results of the Cheetah Research Council Pathology Survey, 1989-1992. Zoo Biology 12: 105-124.
    • Munson L., Nesbit J.W., Meltzer D.G., Colly L.P., Bolton L., Kriek N.P. (1999) Diseases of captive cheetahs (Acinonyx jubatus jubatus ) in South Africa: a 20-year retrospective survey. Journal of Zoo Wildlife and Medicine 30: 342-347.
    • Munson L., Terio K. A., Worley M., Jago M., Bagot-Smith A., Marker L. (2005) Extrinsic factors significantly aefct paetrns of disease in freeranging and captive cheetah (Acinonyx jubatus ) populations. Journal of Wildlife Diseases 41: 542-548.
    • Otoni C.C., Heilmann R.M., Garcia-Sancho M., Suchodolski J.S., Steiner J.M., Jergens A.E. (2012) Serologic and fecal markers in prediction of acute disease course in canine chronic enteropathies. Journal of Veterinary Internal Medicine 26: 768 (abstract).
    • Pedersen G., Brynskov J., Saermark T. (2002) Phenol toxicity and conjugation in human colonic epithelial cells. Scandinavian Journal of Gastroenterology 37: 74-79.
    • Røseth A.G., Fagerhol M.K., Aadland E., Schjonsby H. (1992) Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scandinavian Journal of Gastroenterology 27: 793-798.
    • Roth J., Vogl T., Sorg C., Sunderköetr C. (2003) Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends in Immunology 24: 155-158.
    • Sidler M.A., Leach S.T., Day A.S. (2008) Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflammatory Bowel Disease 14: 359-366.
    • Striz I., Trebichavsky I. (2004) Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiological Research 53: 245-253.
    • Summerton C.B., Longlands M.G., Wiener K., Shreeve D.R. (2002) Faecal calprotectin: a marker of inflammation throughout the intestinal tract. European Journal of Gastroenterology and Hepatology 14: 841-845.
    • Tuohy K.M., Hinton D.J.S., Davies S.J., Crabbe M.J.C., Gibson G.R., Ames J.M. (2006) Metabolism of Maillard reaction products by the human gut microbiota - implications for health. Molecular Nutrition and Food Research 50: 847-857.
    • Weber F.L., Banwell J.G., Fresard K.M., Cummings J.H. (1987) Nitrogen in fecal bacterial, fiber, and soluble fractions of patients with cirrhosis: eefcts of lactulose and lactulose plus neomycin. Journal of Laboratory and Clinical Medicine 110: 259-263.
    • Whitehouse-Tedd K., Lefebre S., Janssens G.P.J. (2012) A global survey of captive cheetah diet, faecal consistency and gastrointestinal disease. In Proceedings of the 14th Annual BIAZA Research Symposium, 10-11 July 2012, Newquay Zoo, UK, p 9.
    • Wong J.M.W., de Souza R., Kendall C.W.C., Emam A., Jenkins D.J.A. (2006) Colonic health: Fermentation and short chain faty acids. Journal of Clinical Gastroenterology 40: 235-243.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article